125 related articles for article (PubMed ID: 28431438)
1. Comparison of Intact Parathyroid Hormone, Alkaline Phosphatase, Phosphate Levels for Diagnosing Severe Metabolic Bone Disease in Infants with Severe Bronchopulmonary Dysplasia.
Tkach EK; White AM; Dysart KC; Waber B; Nawab US; Zhang H; Jensen EA
Am J Perinatol; 2017 Oct; 34(12):1199-1204. PubMed ID: 28431438
[No Abstract] [Full Text] [Related]
2. Bone Mineral Density According to Dual Energy X-ray Absorptiometry is Associated with Serial Serum Alkaline Phosphatase Level in Extremely Low Birth Weight Infants at Discharge.
Lee J; Park HK; Kim JH; Choi YY; Lee HJ
Pediatr Neonatol; 2017 Jun; 58(3):251-257. PubMed ID: 27780689
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone as a marker for metabolic bone disease of prematurity.
Moreira A; Swischuk L; Malloy M; Mudd D; Blanco C; Geary C
J Perinatol; 2014 Oct; 34(10):787-91. PubMed ID: 24875407
[TBL] [Abstract][Full Text] [Related]
4. Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia.
Gaio P; Verlato G; Daverio M; Cavicchiolo ME; Nardo D; Pasinato A; de Terlizzi F; Baraldi E
Clin Nutr ESPEN; 2018 Feb; 23():234-239. PubMed ID: 29460805
[TBL] [Abstract][Full Text] [Related]
5. [Osteopenia of prematurity--prophylaxis, diagnostics and treatment].
Hitrova S; Slancheva B; Popivanova A; Vakrilova L; Pramatarova T; Emilova Z; Yarakova N
Akush Ginekol (Sofiia); 2012; 51(7):24-30. PubMed ID: 23610914
[TBL] [Abstract][Full Text] [Related]
6. How many measurements to make a decision?
Houillier P; Coste J; Froissart M
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1161-2. PubMed ID: 20558565
[No Abstract] [Full Text] [Related]
7. [The effect of osteopenia prevention in very small premature infants on hormonal parameters of calcium metabolism and bone mineralization].
Reinken L; Obladen M; Dockx-Reinken F; Lindemann C
Klin Padiatr; 1989; 201(3):177-82. PubMed ID: 2739343
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism.
Smith GR; Collinson PO; Kiely PD
J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone - reference values and association with other bone metabolism markers in very low birth weight infants - pilot study.
Matejek T; Navratilova M; Zaloudkova L; Malakova J; Maly J; Skalova S; Palicka V
J Matern Fetal Neonatal Med; 2019 Sep; 32(17):2860-2867. PubMed ID: 29562766
[No Abstract] [Full Text] [Related]
10. Determinants of Severe Metabolic Bone Disease in Very Low-Birth-Weight Infants with Severe Bronchopulmonary Dysplasia Admitted to a Tertiary Referral Center.
Jensen EA; White AM; Liu P; Yee K; Waber B; Monk HM; Zhang H
Am J Perinatol; 2016 Jan; 33(1):107-13. PubMed ID: 26295968
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic bone disease in premature infants and genetic polymorphisms].
Funke S; Morava E; Czakó M; Vida G; Ertl T; Kosztolányi G
Orv Hetil; 2007 Oct; 148(41):1957-65. PubMed ID: 17921123
[TBL] [Abstract][Full Text] [Related]
12. [Metabolic Bone Disease of Prematurity in Very Low Birthweight Infants: Retrospective Observational Study].
Costa R; Franco C; Santos N; Maio P; Vieira F; Antunes S; Martins L; Tuna ML
Acta Med Port; 2019 Aug; 32(7-8):536-541. PubMed ID: 31445534
[TBL] [Abstract][Full Text] [Related]
13. Bone mineralisation in premature infants cannot be predicted from serum alkaline phosphatase or serum phosphate.
Faerk J; Peitersen B; Petersen S; Michaelsen KF
Arch Dis Child Fetal Neonatal Ed; 2002 Sep; 87(2):F133-6. PubMed ID: 12193522
[TBL] [Abstract][Full Text] [Related]
14. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
[TBL] [Abstract][Full Text] [Related]
15. How to use... alkaline phosphatase in neonatology.
Tinnion RJ; Embleton ND
Arch Dis Child Educ Pract Ed; 2012 Aug; 97(4):157-63. PubMed ID: 22761487
[TBL] [Abstract][Full Text] [Related]
16. Does PTH offer additive value to ALP measurement in assessing CKD-MBD?
Lamb EJ; Delaney MP
Perit Dial Int; 2014; 34(7):687-91. PubMed ID: 25520480
[No Abstract] [Full Text] [Related]
17. Metabolic Bone Disease of Prematurity: Risk Factors and Associated Short-Term Outcomes.
Avila-Alvarez A; Urisarri A; Fuentes-Carballal J; Mandiá N; Sucasas-Alonso A; Couce ML
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33321828
[TBL] [Abstract][Full Text] [Related]
18. Skeletal changes in preterm infants.
Koo WW; Gupta JM; Nayanar VV; Wilkinson M; Posen S
Arch Dis Child; 1982 Jun; 57(6):447-52. PubMed ID: 6979978
[TBL] [Abstract][Full Text] [Related]
19. Elevated Alkaline Phosphatase in Infants With Parenteral Nutrition-Associated Liver Disease Reflects Bone Rather Than Liver Disease.
Nandivada P; Potemkin AK; Carlson SJ; Chang MI; Cowan E; O'Loughlin AA; Gura KM; Puder M
JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):973-6. PubMed ID: 25106918
[TBL] [Abstract][Full Text] [Related]
20. Lanthanum carbonate: a postmarketing observational study of efficacy and safety.
Rombolà G; Londrino F; Corbani V; Falqui V; Ardini M; Zattera T;
J Nephrol; 2012; 25(4):490-6. PubMed ID: 22476966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
